Formulation Development of Ambroxol Hydrochloride Soft Gel with Application of Statistical Experimental Design and Response Surface Methodology

References

1. 1.↵
   1. Lewis G. A.,
   2. Mathiue D.,
   3. Phan-Tan-Luu R.

   Pharmaceutical Experimental Design; Marcel Dekker, Inc.: New York, 1999; p 112.
2. 2.↵
   1. Kaushik D.,
   2. Dureja H.,
   3. Saini T. R.

   Mouth dissolving tablets: a review. Indian Drugs 2004, 41 (4), 187–193.

   OpenUrl
3. 3.↵
   1. Habib W.,
   2. Khanhari R.,
   3. Hontz J.

   Fast-dissolve drug delivery systems. Crit. Rev. Ther. Drug Carrier Sys. 2000, 17 (1), 61–72.

   OpenUrlPubMed
4. 4.↵
   1. Bertelsen P.,
   2. Hansen N. G.,
   3. Ruckendorfer H.,
   4. Itai S.

   Quick Release Pharmaceutical Compositions of Drug Substances. U.S. Patent 6,713,089, 2004.
5. 5.↵
   1. Abu-Izza K. A.,
   2. Li V. H.,
   3. Look J. L.,
   4. Parr G. D.,
   5. Schineller G. A.

   Fast Dissolving Tablet. U.S. Patent 6,733,751, 2004.
6. 6.↵
   1. Bogner R. H.,
   2. et al

   . Fast-dissolving tablets. Welcome to US pharmacist, 2003.
7. 7.↵
   1. Watanabe Y.,
   2. Koizumi K.,
   3. Zama Y.,
   4. Kiriyama M.,
   5. Matsumoto Y.,
   6. Matsumoto M.

   New compressed tablet rapidly disintegrating in saliva in the mouth using crystalline cellulose and a disintegrant. Biol. Pharm. Bull. 1995, 18 (9), 1308–1310.

   OpenUrlPubMed
8. 8.↵
   1. Koizumi K.,
   2. Watanabe Y.,
   3. Morita K.,
   4. Utoguchi N.,
   5. Matsumoto M.

   New method of preparing high porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material. Int. J. Pharm. 1997, 152 (1), 127–131.

   OpenUrl
9. 9.↵
   1. Virley P.,
   2. Yarwood R. J.

   Zydis—a novel, fast dissolving dosage form. Manuf. Chem. 1990, 36, 36–37.

   OpenUrl
10. 10.↵
    1. Ishikawa T.,
    2. Watanabe Y.,
    3. Utoguchi N.,
    4. Matsumoto M.

    Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter taste masked granules by the compression method. Chem. Pharm. Bull. 1999, 47 (10), 1451–1454.

    OpenUrlPubMed
11. 11.↵
    1. Rajyaguru T. H.,
    2. Indurwade N. H.,
    3. Nahkhat P. D.

    Novel approach—fast dissolving tablets. Indian Drugs 2002, 39 (8), 405–409.

    OpenUrl
12. 12.↵
    1. Nadendla R. R.,
    2. Sudhakar G.,
    3. Srinath N.

    Current status of dispersible dosage forms. Int. J. Pharma. Excip. 2002, 2, 25–28.

    OpenUrl
13. 13.↵
    www.cpkelco.com.
14. 14.↵
    Gellan Gum for Pharmaceutical Applications rev. 10/99, Kelco Biopolymers Gellan Gum Gel (G³) A New Self-Lubricated, Easy to Swallow, Oral Dosage Form rev. 10/99, Kelco Biopolymers, pformulate/01/25/2004.
15. 15.↵
    1. Sworn G.,
    2. Kasapis S.

    Effect of conformation and molecular weight of co-solute on the mechanical properties of gellan gum gels. Food Hydrocolloids 1998, 12 (3), 283–290.

    OpenUrl
16. 16.↵
    Kelcogel® Gellan Gum: A Multifunctional Gelling Agent. San Diego: CP Kelco, www.cpkelco.com, accessed December 1, 2005.
17. 17.↵
    1. Fialho A. M.,
    2. Martins L. O.,
    3. Donval M. L.,
    4. Jorge H. L.,
    5. Michael J. R.,
    6. Andrew J. J.,
    7. Victor J. M.,
    8. Isabel S.

    Structures and properties of gellan polymers produced by Sphingomonas paucimobilis ATCC 31461 from lactose compared with those produced from glucose and from cheese whey. Appl. Environ. Microbiol. 1999, 65 (6), 2485–2491.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Jansson P. E.,
    2. Lindberg B.,
    3. Sandford P. A.

    Structural studies of gellan gum an extracellular polysaccharide elaborated by Pseudomonas elodea. Carbohydr. Res. 1983, 124 (1), 135–139.

    OpenUrlCrossRef
19. 19.↵
    1. Deasy P. B.,
    2. Quigley J.

    Rheological evaluation of deacylated gellan gum (Gelrite) for pharmaceutical use. Int. J. Pharm. 1991, 73 (2), 117–123.

    OpenUrl
20. 20.↵
    1. Bayarri S.,
    2. Rivas I.,
    3. Costell E.,
    4. Duran L.

    Diffusion of sucrose and aspartame in kappa-carrageenan and gellan gum gels. Food Hydrocolloids 2001, 15 (1), 67–73.

    OpenUrl
21. 21.↵
    Kelcogel® Gellan Gum: A Multifunctional Gelling Agent. San Diego: CP Kelco, www.cpkelco.com, accessed on December 1, 2005.
22. 22.↵
    www.pformulate.com.
23. 23.↵
    1. Grasdalen H.,
    2. Smidsrod O.

    Gelation of gellan gum. Carbohydr. Polym. 1987, 7 (5), 371–393.

    OpenUrl
24. 24.↵
    1. Nowak D.,
    2. Antczak A.,
    3. Król M.,
    4. Bialasiewicz P.,
    5. Pietras T.

    Antioxidant properties of ambroxol. Free Radic. Biol. Med. 1994, 16 (4), 517–522.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Ericsson C. H.,
    2. Juhasz J.,
    3. Jöhnson E.,
    4. Mossberg B.

    Ambroxol and simple chronic bronchitis: effects on subjective symptoms and ventilatory function. Respiration 1987, 51 (Suppl 1), 33–36.

    OpenUrlPubMed
26. 26.↵
    1. Guyatt G. H.,
    2. Townsend M.,
    3. Kazim F.,
    4. Newhouse M. T.

    A controlled trial of ambroxol in chronic bronchitis. Chest. 1987, 92 (4), 618–620.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Ratjen F.,
    2. Wonne R.,
    3. Posselt H. G.,
    4. Stover B.,
    5. Hofmann D.,
    6. Bender S. W.

    A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis. Eur. J. Pediatr. 1985, 144 (4), 374–378.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Vergin H.,
    2. Bishop-Freundling G. B.,
    3. Micka M.,
    4. Nitsche V.,
    5. Strobel K.,
    6. Matzkies F.

    Untersuchungen zur pharmakokinetik und bioaquivalenz unterschiedlicher darreichungs formenvon ambroxol. Arzneim-Forsch./Drug Res. 1985, 35, 1591–1595.

    OpenUrl
29. 29.↵
    1. Basak S. C.,
    2. Jayakumar Reddy B. M.,
    3. Lucas Mani K. P.

    Formulation and release behaviour of sustained release ambroxol hydrochloride HPMC matrix tablet. Indian J. Pharm. Sci. 2006, 68 (5), 594–598.

    OpenUrl
30. 30.↵
    1. Grasdalen H.,
    2. Smidsrod O.

    Gelation of gellan gum. Carbohydr. Polym. 1987, 7 (5), 371–393.

    OpenUrl
31. 31.↵
    1. Horinaka J.,
    2. Kani K.,
    3. Hori Y.,
    4. Maeda S.

    Effect of pH on the conformation of gellan chains in aqueous systems. Biophys. Chem. 2004, 111 (3), 223–227.

    OpenUrlPubMed
32. 32.↵
    1. Rowe R. C.,
    2. Sheshkey P. J.,
    3. Weller P. J.

    Handbook of Pharmaceutical Excepients, 4th ed.; Pharmaceutical Press: London, Chicago, 2003.
33. 33.↵
    1. Camelin I.,
    2. Lacroix C.,
    3. Paquin C.,
    4. Prevost H.,
    5. Cachon R.,
    6. Divies C.

    Effect of chelatants on gellan gel rheological properties and setting temperature for immobilization of living bifidobacteria. Biotechnol. Prog. 1993, 9 (3), 291–297.

    OpenUrlCrossRefPubMed
34. 34.↵
    1. El-Kamel A.,
    2. Al-Dosari H.,
    3. Al-Jenoobi F.

    Environmentally responsive ophthalmic gel formulation of carteolol hydrochloride. Drug Deliv. 2006, 13 (1), 55–59.

    OpenUrlPubMed
35. 35.↵
    1. Sworn G.,
    2. Kasapis S.

    The use of Arrhenius and WLF kinetics to rationalize the mechanical spectrum in high sugar gellan system. Carbohydr. Res. 1998, 309, 353–361.

    OpenUrl
36. 36.↵
    1. Pokharkar V. B.

    Taste Masking of Pharmaceuticals, available at www.pharmainfo.net, accessed 2005.
37. 37.↵
    1. Gaspar C.,
    2. Laureano O.,
    3. Sousa I.

    Production of reduced-calorie grape juice jelly with gellan, xanthan and locust bean gums: sensory and objective analysis of texture. Z. Lebensm. Unters. Forsch A 1998, 206 (3), 169–174.

    OpenUrl
38. 38.↵
    1. Mashimo S.,
    2. Shinyashiki N.,
    3. Matsumura Y.

    Water structure in gellan gum-water system. Carbohydrate Polymers 1996, 30 (2–3), 141–144.

    OpenUrl